“…Enantiomerically enriched α-substituted-β-hydroxy phosphonates have attracted considerable interests because of their wide range of biological activities as well as their abilities to serve as surrogates of the corresponding β-hydroxy carboxylates. − These substances are also key intermediates in the synthesis of potentially important peptide analogues, enzyme inhibitors, phosphonic acid-based antibiotics, and drug candidates. ,− Although a number of methods have been described for the preparation of enantiomerically enriched β-hydroxy phosphonates, including enzymatic − and nonenzymatic resolutions of racemic mixtures, − most suffer from either low levels of stereoselectivitiy or poor efficiencies. Enantiomerically enriched α-substituted-β-hydroxy phosphonates have also been prepared by utilizing asymmetric C–P bond-forming reactions of chiral α-hydroxy aldehydes with phosphonates. , However, these approaches require the use of stoichiometric amounts of chiral starting materials and the observed stereoselectivities of the formed chiral 1,2-dihydroxy phosphonates are not high. , In some cases, Sharpless asymmetric dihydroxylation of α,β-unsaturated phosphonates was used to generate 1,2-dihydroxy phosphonates with high levels of stereoselectivity. − However, in this case the need exists to discriminate between the hydroxyl groups in the 1,2-dihydroxy phosphonate moiety when selective transformations to produce α-substituted-β-hydroxy phosphonates are desired.…”